🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is #AddisonsDiseaseDay. This year's theme is "Know the Signs, Save a Life" to highlight the importance of low cortisol and the Sick Day Rules. Learn more about #AddisonsDisease, the Sick Day Rules and how you can make a difference👉 bit.ly/AddisonsDiseas… Addison's Disease Self-Help Group (ADSHG)

Low-renin hypertension despite the use of ACE inhibitors or ARBs is almost certainly a form of primary aldosteronism. Thrilled to know that our group's work is the featured article in this month's issue of hypertension ! ahajournals.org/doi/full/10.11… Anand Vaidya Jen Brown

Serum proteomic signatures raise new possibilities for distinguishing primary aldosteronism from essential hypertension! Our latest study is now published in the European Journal of Clinical Investigation! onlinelibrary.wiley.com/doi/10.1111/ec… Anand Vaidya European Journal of Clinical Investigation

Excited to share this important work showing sodium reduction lowered BP in the context of diabetes. Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes jamanetwork.com/journals/jamai…

Response: clinical and biochemical, to Primary aldosteronism with mineralocorticoid antagonists - with the occasional remission? 🔗 academic.oup.com/ajh/article/38… 🔒 #PA #MRA #Hypertension

A great getaway - just an hour away from Bangkok!

Blood pressure and its associations in 554 children and young people with congenital adrenal hyperplasia by Neil R Lawrence et al Nils Krone EJE Volume 192, Issue 5, May 2025 Open access 👉 doi.org/10.1093/ejendo… #endocrinology #CAH #glucocorticoids #hyperplasia

Adrenal Insufficiency

Using an MRA empiricially or renin-guided therapy in apparent treatment resistant hypertension? academic.oup.com/ajh/article/29… #WeekendReads from the #EditorsChoice archives

Catalyst 2 trial is published!! #ADA2025 #ADASciSessions diabetesjournals.org/care/article/d…

#CoMICWednesday #EJECoMICs Ep 58: NEW Euro J Endocrinology paper: Impact of hydrocortisone versus prednisone therapy on post-surgical recovery in patients with endogenous hypercortisolism Full article doi.org/10.1093/ejendo… By @SimbaComics led by Mukunth Kowsik 👉 youtu.be/6yAUrp3V5LA

Our UK Non-functioning Pituitary Adenoma Consortium papers in this guideline Conservatively managed non-functioning pituitary macroadenomas doi.org/10.1093/ejendo… Natural history of non-functioning pituitary microadenomas doi.org/10.1093/ejendo…

Big data determination and validation of reference range for 24-h urine cortisol by liquid chromatography-mass spectrometry by Gregory A Kline et al EJE Volume 192, Issue 4, April 2025 Open access 👉 doi.org/10.1093/ejendo…

Resolution of paradoxical bilateral aldosterone suppression with mass spectrometry by Taweesak Wannachalee Adina Turcu et al EJE Volume 192, Issue 4, April 2025 Full article 👉 doi.org/10.1093/ejendo… ESE members free via 👉 my.ese-hormones.org

Sexual dimorphism in benign adrenocortical tumours by Onnicha Suntornlohanakul, Cristina L Ronchi, Wiebke Arlt, Alessandro Prete Alessandro Prete EJE Volume 192, Issue 5, May 2025 Open access 👉 doi.org/10.1093/ejendo…

Presented at #ENDO2025: In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results:

Real-world outcomes of finerenone in primary aldosteronism by Dipika R Mohan Thomas Uslar et al EJE Volume 192, Issue 5, May 2025 Full article 👉 doi.org/10.1093/ejendo… ESE members free via 👉 my.ese-hormones.org #endocrinology #finerenone #primaryaldosteronism

Having fun at #ENDO2025 Happy to meet with mentors, friends, colleagues and collaborators! Anand Vaidya Jen Brown Cheng-Hsuan Tsai Troy Puar EzgiCG Two more days to go before heading back home!

New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic. academic.oup.com/jcem/advance-a…

It was great presenting a poster at #ENDO2025. I received lots of constructive comments today. Thank you for all the comments, and thank you to my colleagues for making this happen!